These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36619145)

  • 1. Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review.
    Hormati A; Arezoumand A; Dokhanchi H; Pezeshgi Modarres M; Ahmadpour S
    Middle East J Dig Dis; 2022 Apr; 14(2):155-166. PubMed ID: 36619145
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
    Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse PR; Vollenberg R; Nowacki TM
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
    Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)].
    Jantchou P; Monnet E; Carbonnel F
    Gastroenterol Clin Biol; 2006; 30(6-7):859-67. PubMed ID: 16885870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
    Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.
    Weaver KN; Kappelman MD; Long MD
    Gastroenterol Hepatol (N Y); 2022 Jul; 18(7):388-399. PubMed ID: 36397773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
    Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
    Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the Lockdown Due to the COVID-19 Pandemic on Patients With Inflammatory Bowel Disease.
    Nishida Y; Hosomi S; Fujimoto K; Nakata R; Sugita N; Itani S; Nadatani Y; Fukunaga S; Otani K; Tanaka F; Nagami Y; Taira K; Kamata N; Watanabe T; Ohfuji S; Fujiwara Y
    Front Med (Lausanne); 2021; 8():649759. PubMed ID: 34957131
    [No Abstract]   [Full Text] [Related]  

  • 16. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.
    Kamath C; Brenner EJ
    Curr Res Pharmacol Drug Discov; 2022; 3():100101. PubMed ID: 35496814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in patients with inflammatory bowel disease.
    Anikhindi SA; Kumar A; Arora A
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
    Ling KL; Hilmi I; Raja Ali RA; Leong RWL; Leung WK; Ng SC; Wu KC; Chen MH; Ran ZH; Hisamatsu T; Ahuja V; Makharia GK; Banerjee R; Wei SC; Wu DC; Pisespongsa P; Ye BD; Sollano J; Simadibrata M; Chuah SW; Ooi CJ
    JGH Open; 2020 Jun; 4(3):320-323. PubMed ID: 32514431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Lytras T; Bonovas S
    Gastroenterology; 2019 Sep; 157(3):647-659.e4. PubMed ID: 31014995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy.
    Castiglione F; Diaferia M; Morace F; Labianca O; Meucci C; Cuomo A; Panarese A; Romano M; Sorrentini I; D'Onofrio C; Caporaso N; Rispo A
    J Crohns Colitis; 2012 Apr; 6(3):324-9. PubMed ID: 22405169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.